BackHTG Molecular Diagnostics Overview

HTG Molecular Diagnostics Total Assets

Track HTG Molecular Diagnostics's total assets ($11M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$10.87M
↓ 61.83% YoYΔ $-17.60M vs prior year quarter

Peer trimmed avg / median

Loading

HTG Molecular Diagnostics Total Assets History

Loading

HTG Molecular Diagnostics vs. peers: Total Assets Comparison

Loading

HTG Molecular Diagnostics Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

HTG Molecular Diagnostics (HTGM) FAQ

HTG Molecular Diagnostics (HTGM) currently reports a total assets of $11M as of March 2023. That compares with $28M in the prior-year period — down 61.8% year over year. Use the charts on this page to explore HTG Molecular Diagnostics's total assets history and peer comparisons.

HTG Molecular Diagnostics's total assets decreased from $28M to $11M — a 61.8% year-over-year decrease (period ending March 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

HTG Molecular Diagnostics reported $11M in total assets as of March 2023. That compares with $28M in the prior-year period — down 61.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $11M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for HTG Molecular Diagnostics, and consider following HTGM for alerts when major investors trade the stock.

HTG Molecular Diagnostics is classified in the Healthcare sector. On total assets, it currently shows $11M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing HTGM with unrelated industries.